Home » News » Symposium The clinical utility of bacteriaphages – 22 February

Symposium The clinical utility of bacteriaphages – 22 February

Bacteriophages received considerable attention in the lay press in the Netherlands recently. Their use was presented as the – logical and easily available – solution to the global crisis in antibiotic resistance. Since then, physicians have been confronted – on the one hand – with questions from patients with difficult-to-treat infections and – on the other hand – with critical comments from colleagues that the clinical benefits of phage therapy have not yet been firmly established. To provide the necessary evidence carefully designed clinical trials are needed. To optimally design such trials UMC Utrecht has invited international experts in bacteriophage therapy to present their experiences with this approach on 22 February in Utrecht.

The symposium is intended for medical doctors and clinical scientists with an interest in the topic of bacteriophage therapy.

This symposium is organized in collaboration with the Netherlands Centre for One Health (NCOH).

More information about the programme and the way to purchase tickets: http://www.umcutrecht.nl/en/Research/Research-programs/Infection-Immunity/Symposium-the-clinical-utility-of-bacteriaphages.

More News

Masterclass Globally prepared for future outbreaks of ‘Disease X’

Leading scientists Jeremy Farrar, Marion Koopmans, and Ron Fouchier will take you into the world of new infectious diseases outbreaks and show you how we can prepare for these outbreaks.


Why do people who live near goat farms have a higher chance of developing pneumonia?

People who live in the vicinity of a goat farm have a higher chance of developing pneumonia. That was demonstrated by the study “Livestock farming and the health of neighbouring residents (VGO)”, which was carried out in Oost-Brabant and Noord-Limburg. The possible causes of this are still not known. On behalf of the Ministry of...


NCOH participates in the EU-funded project One Health European Joint Programme (One Health EJP)

NCOH Partners are involved in a recently-granted One Health European Joint Programme, which started last January. In the One Health EJP, 39 partners from 19 EU member states are gathered to create a sustainable European One Health framework by integration and alignment of medical, veterinary and food institutes through joint programming of research agendas matching...



Antimicrobial resistance (AMR) is a growing problem worldwide, and with few new drugs making it to the market, there is an urgent need for new medicines to treat resistant infections. The COMBACTE (COMBatting AntimiCrobial resisTance in Europe) project aims to give antibiotic drug development a much-needed boost by pioneering new ways of designing and implementing...